secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001477449-24-000017
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q4 2023 revenue $660.5M, adj. EBITDA up 22% to $114.4M; guides FY2024 revenue $2.64-2.74B
--------------------------------------------------------------------------------

- Q4 revenue $660.5M (+4% YoY); Full year revenue $2,602.4M (+8% YoY).
- Q4 net loss $28.9M ($0.17/sh) vs $3.81B loss a year ago; FY net loss $220.4M ($1.34/sh).
- Q4 adjusted EBITDA $114.4M (+22% YoY); FY adj. EBITDA $328.1M (+33% YoY); FY free cash flow $193.7M.
- FY2024 guidance: revenue $2,635-2,735M, adj. EBITDA $350-390M, free cash flow $210-240M.
- Efficiency program targets ~$43M net expense reduction in 2024; expects $85M annualized savings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000017/0001477449-24-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000017/tdoc-20240220.htm
  HTML page:      https://secwatch.observer/filing/0001477449-24-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer